|
|
|
|
LEADER |
03492nam a2200637Ia 4500 |
001 |
10.1016-j.jmsacl.2021.09.004 |
008 |
220427s2021 CNT 000 0 und d |
020 |
|
|
|a 2667145X (ISSN)
|
245 |
1 |
0 |
|a Rapid identification of plasmalogen molecular species using targeted multiplexed selected reaction monitoring mass spectrometry
|
260 |
|
0 |
|b Elsevier B.V.
|c 2021
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.jmsacl.2021.09.004
|
520 |
3 |
|
|a Plasmalogens (Pls) levels are reported to be altered in several neurological and metabolic diseases. Identification of sn-1 fatty alcohols and sn-2 fatty acids of different Pls species is necessary to determine the roles and mechanisms of action of Pls in different diseases. Previously, full-scan tandem mass spectrometry (MS/MS) was used for this purpose but is not effective for low-abundance Pls species. Recently, multiplexed selected reaction monitoring MS (SRM/MS) was found to be more selective and sensitive than conventional full-scan MS/MS for the identification of low-abundance compounds. In the present study, we developed a liquid chromatography (LC)-targeted multiplexed SRM/MS system for the identification and quantification of different Pls choline (Pls-PC) and Pls ethanolamine (Pls-PE) species. We determined five precursor-product ion transitions to identify sn-1 and sn-2 fragments of each Pls species. Consequently, sn-1 and sn-2 fatty acyl chains of 22 Pls-PC and 55 Pls-PE species were identified in mouse brain samples. Among them, some species had C20:0 and C20:1 fatty alcohols at the sn-1 position. For quantification of Pls species in mouse brain samples, a single SRM transition was employed. Thus, our results suggest that the LC-targeted multiplexed SRM/MS system is very sensitive for the identification and quantification of low-abundance lipids such as Pls, and is thus expected to make a significant contribution to basic and clinical research in this field in the future. © 2021 THE AUTHORS
|
650 |
0 |
4 |
|a animal experiment
|
650 |
0 |
4 |
|a animal model
|
650 |
0 |
4 |
|a animal tissue
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a clinical research
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a electrospray
|
650 |
0 |
4 |
|a ethanolamine
|
650 |
0 |
4 |
|a high performance liquid chromatography
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a human tissue
|
650 |
0 |
4 |
|a icosapentaenoic acid
|
650 |
0 |
4 |
|a Identification
|
650 |
0 |
4 |
|a LC-MS/MS
|
650 |
0 |
4 |
|a limit of detection
|
650 |
0 |
4 |
|a linoleic acid
|
650 |
0 |
4 |
|a liquid chromatography
|
650 |
0 |
4 |
|a liquid chromatography-mass spectrometry
|
650 |
0 |
4 |
|a male
|
650 |
0 |
4 |
|a mass spectrometry
|
650 |
0 |
4 |
|a metabolic disorder
|
650 |
0 |
4 |
|a molecule
|
650 |
0 |
4 |
|a mouse
|
650 |
0 |
4 |
|a multiple reaction monitoring
|
650 |
0 |
4 |
|a multiple sclerosis
|
650 |
0 |
4 |
|a nonhuman
|
650 |
0 |
4 |
|a palmitic acid
|
650 |
0 |
4 |
|a Phospholipids
|
650 |
0 |
4 |
|a plasmalogen
|
650 |
0 |
4 |
|a Plasmalogens
|
650 |
0 |
4 |
|a Quantification
|
650 |
0 |
4 |
|a saturated fatty acid
|
650 |
0 |
4 |
|a tandem mass spectrometry
|
650 |
0 |
4 |
|a Targeted multiplexed SRM/MS‘
|
650 |
0 |
4 |
|a thin layer chromatography
|
700 |
1 |
|
|a Ahsanul Haque, M.
|e author
|
700 |
1 |
|
|a Azad, A.K.
|e author
|
700 |
1 |
|
|a Kobayashi, H.
|e author
|
700 |
1 |
|
|a Md. Sheikh, A.
|e author
|
700 |
1 |
|
|a Nagai, A.
|e author
|
700 |
1 |
|
|a Osago, H.
|e author
|
700 |
1 |
|
|a Sakai, H.
|e author
|
700 |
1 |
|
|a Yano, S.
|e author
|
773 |
|
|
|t Journal of Mass Spectrometry and Advances in the Clinical Lab
|